CTOR
Citius Oncology, Inc.
NASDAQ · Healthcare · Drug Manufacturers - General · US
$0.86
+8.56%Leverage
- Debt / equity
- 0.25x
- Net debt / equity
- -0.16x
- Debt / assets
- 0.09x
- Debt / EBITDA
- -0.24x
- Net debt / EBITDA
- 0.15x
Liquidity & coverage
- Current ratio
- 0.73x
- Quick ratio
- 0.34x
- Cash ratio
- 0.28x
- Interest coverage
- -86.40x
- EBITDA / interest
- -78.79x
- Working capital
- -$16.1M
Cash & dividend
- FCF / debt
- -1.93x
- Cash flow / debt
- -1.93x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026